SCHEMBL16634971

SCHEMBL16634971

NCc1ccnc(-c2cccnc2)c1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.44
CYP2A6 P11509 8/20 0.43
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PTK2 Q05397 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CYP2C9 P11712 4/20 0.40
CYP2B6 P20813 4/20 0.40
CYP2C19 P33261 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2E1 P05181 3/20 0.40
CYP2D6 P10635 3/20 0.40
KCNA5 P22460 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
TDO2 P48775 1/20 0.38
CCNK O75909 1/20 0.38
CDK12 Q9NYV4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31608486 0.79 CYP2A6 (0.47) CYP2A6CDK5CDK5R1SMN1; SMN2CYP2C9
SCHEMBL30332536 0.77 CYP2A6 (0.56) LOXL2CYP2A6CDK5CDK5R1SMN1; SMN2
SCHEMBL9400328 0.77 CYP2A6 (0.56) LOXL2CYP2A6CDK5CDK5R1SMN1; SMN2
SCHEMBL30115268 0.70 CYP2A6 (0.56) CYP2A6SMN1; SMN2CYP3A4ALDH1A1CYP1A2
SCHEMBL3138189 0.70 CYP2A6 (0.56) CYP2A6SMN1; SMN2CYP3A4ALDH1A1CYP1A2
SCHEMBL28225656 0.69 KCNA5 (0.43) LOXL2CYP2A6HSP90AA1HSP90AB1PTK2
SCHEMBL7092910 0.68 CYP2A6 (0.67) CYP2A6HSP90AA1HSP90AB1PTK2CDK5
SCHEMBL29852394 0.68 NPC1 (0.41) CYP2A6HSP90AA1HSP90AB1PTK2CDK5
SCHEMBL30607540 0.67 DPP4 (0.43) LOXL2KCNA5
SCHEMBL3288789 0.65 DPP4 (0.62) LOXL2CYP2A6CYP2C9CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055302-A1 SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS F. Hoffmann-La Roche AG (CH) 2016-08-17 EP disclosed
WO-2015052264-A1 SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2015-04-16 WO disclosed